Related Experiment Video

Updated: Aug 14, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Interleukin-2 for the treatment of melanoma

Ahmad A Tarhini1, Sanjiv S Agarwala

  • 1University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, 5th Floor, Pittsburgh, PA 15232, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|December 24, 2005
PubMed

Insights

Current advanced melanoma treatments are insufficient. High-dose Interleukin-2 (IL-2) immunotherapy offers limited durable remissions, while other IL-2 schedules and biochemotherapy show no survival benefit. Novel IL-2 gene therapies are under investigation.

Area of Science:

  • Oncology
  • Immunotherapy
  • Melanoma Treatment

Background:

  • Advanced melanoma treatment options remain inadequate.
  • Dacarbazine chemotherapy is a standard but lacks proven survival benefits.
  • High-dose bolus Interleukin-2 (IL-2) yields limited durable remissions in metastatic melanoma.

Purpose of the Study:

  • To evaluate the efficacy of different Interleukin-2 (IL-2) administration schedules for advanced melanoma.
  • To compare IL-2-based therapies with chemotherapy and biochemotherapy.
  • To explore novel therapeutic strategies for advanced melanoma.

Main Methods:

  • Review of randomized clinical trials comparing IL-2 regimens with chemotherapy.
  • Analysis of high-dose bolus IL-2, continuous infusion IL-2, and biochemotherapy efficacy.
  • Assessment of low-dose IL-2 effectiveness and toxicity.

Main Results:

  • High-dose bolus IL-2 provides a small number of durable remissions.
  • Continuous infusion IL-2, alone or with chemotherapy (biochemotherapy), did not improve response rates over chemotherapy alone.
  • Low-dose IL-2 shows low response rates and ineffectiveness in metastatic melanoma.

Conclusions:

  • Current IL-2 immunotherapy regimens offer limited benefits for advanced melanoma.
  • Innovative approaches like IL-2 gene therapy are needed.
  • Further research is crucial to develop more effective melanoma treatments.

More Related Videos

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...